Elizabeth Tkachenko, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Isotretinoin | 4 | 2020 | 134 | 1.510 |
Why?
|
Alopecia Areata | 4 | 2021 | 130 | 1.440 |
Why?
|
Fasciitis | 2 | 2020 | 66 | 1.280 |
Why?
|
Dermatologic Agents | 3 | 2020 | 313 | 1.140 |
Why?
|
Acne Vulgaris | 3 | 2020 | 352 | 1.050 |
Why?
|
Alopecia | 5 | 2021 | 416 | 0.890 |
Why?
|
Mycophenolic Acid | 2 | 2020 | 348 | 0.740 |
Why?
|
Porphyria Cutanea Tarda | 1 | 2021 | 12 | 0.740 |
Why?
|
Eyebrows | 1 | 2020 | 38 | 0.700 |
Why?
|
Soaps | 1 | 2019 | 30 | 0.660 |
Why?
|
Ticks | 1 | 2019 | 71 | 0.650 |
Why?
|
Massage | 1 | 2019 | 86 | 0.640 |
Why?
|
Tick-Borne Diseases | 1 | 2019 | 37 | 0.640 |
Why?
|
Vitiligo | 1 | 2019 | 97 | 0.590 |
Why?
|
Scleroderma, Systemic | 1 | 2021 | 346 | 0.550 |
Why?
|
Efficiency | 1 | 2019 | 479 | 0.510 |
Why?
|
Complementary Therapies | 1 | 2019 | 487 | 0.510 |
Why?
|
Eosinophilia | 1 | 2020 | 556 | 0.500 |
Why?
|
Immunoglobulins, Intravenous | 1 | 2019 | 667 | 0.490 |
Why?
|
Dermatology | 3 | 2020 | 905 | 0.480 |
Why?
|
Skin Neoplasms | 6 | 2020 | 5863 | 0.400 |
Why?
|
Immunosuppressive Agents | 2 | 2020 | 4206 | 0.350 |
Why?
|
Heterosexuality | 2 | 2020 | 309 | 0.290 |
Why?
|
Patient Satisfaction | 1 | 2019 | 3488 | 0.260 |
Why?
|
Mental Health | 1 | 2020 | 3275 | 0.260 |
Why?
|
Latent Tuberculosis | 2 | 2020 | 224 | 0.250 |
Why?
|
Severity of Illness Index | 2 | 2021 | 15948 | 0.220 |
Why?
|
Eyelashes | 1 | 2021 | 20 | 0.180 |
Why?
|
Delivery of Health Care | 1 | 2019 | 5367 | 0.180 |
Why?
|
Cellulitis | 1 | 2022 | 206 | 0.180 |
Why?
|
Mental Disorders | 1 | 2020 | 6874 | 0.180 |
Why?
|
Alanine Transaminase | 2 | 2020 | 606 | 0.170 |
Why?
|
Observer Variation | 3 | 2021 | 2622 | 0.170 |
Why?
|
Gender Identity | 3 | 2020 | 770 | 0.170 |
Why?
|
Private Practice | 1 | 2020 | 154 | 0.170 |
Why?
|
Scleroderma, Localized | 1 | 2020 | 85 | 0.160 |
Why?
|
Necrobiosis Lipoidica | 1 | 2019 | 14 | 0.160 |
Why?
|
Sunbathing | 1 | 2020 | 66 | 0.160 |
Why?
|
Pityriasis Rubra Pilaris | 1 | 2019 | 20 | 0.160 |
Why?
|
Investments | 1 | 2020 | 149 | 0.160 |
Why?
|
Lupus Erythematosus, Cutaneous | 1 | 2019 | 75 | 0.150 |
Why?
|
Liver Function Tests | 1 | 2020 | 526 | 0.150 |
Why?
|
Photography | 1 | 2020 | 537 | 0.140 |
Why?
|
Hair | 1 | 2020 | 508 | 0.140 |
Why?
|
Health Expenditures | 2 | 2019 | 2389 | 0.130 |
Why?
|
Adverse Drug Reaction Reporting Systems | 1 | 2019 | 496 | 0.130 |
Why?
|
Withholding Treatment | 1 | 2020 | 620 | 0.120 |
Why?
|
Humans | 30 | 2022 | 768166 | 0.120 |
Why?
|
Prevalence | 6 | 2020 | 15869 | 0.120 |
Why?
|
Young Adult | 9 | 2021 | 60066 | 0.110 |
Why?
|
Social Stigma | 1 | 2021 | 788 | 0.110 |
Why?
|
Risk-Taking | 1 | 2020 | 1023 | 0.110 |
Why?
|
Patient Care | 1 | 2020 | 629 | 0.110 |
Why?
|
Diagnostic Tests, Routine | 1 | 2020 | 789 | 0.110 |
Why?
|
Retrospective Studies | 8 | 2020 | 81762 | 0.110 |
Why?
|
Quality of Life | 3 | 2019 | 13490 | 0.110 |
Why?
|
Female | 21 | 2021 | 397192 | 0.110 |
Why?
|
Sexual Behavior | 2 | 2020 | 2197 | 0.110 |
Why?
|
Male | 20 | 2021 | 364719 | 0.100 |
Why?
|
Adult | 15 | 2021 | 223646 | 0.100 |
Why?
|
Psoriasis | 1 | 2020 | 926 | 0.100 |
Why?
|
Cross-Sectional Studies | 7 | 2022 | 26379 | 0.100 |
Why?
|
Immunity, Humoral | 1 | 2016 | 610 | 0.100 |
Why?
|
Patient Preference | 1 | 2019 | 946 | 0.100 |
Why?
|
United States | 10 | 2020 | 73039 | 0.100 |
Why?
|
Health Care Surveys | 1 | 2019 | 2434 | 0.100 |
Why?
|
United States Food and Drug Administration | 1 | 2020 | 1673 | 0.090 |
Why?
|
Skin Diseases | 1 | 2019 | 1085 | 0.090 |
Why?
|
Biological Products | 1 | 2020 | 948 | 0.090 |
Why?
|
Antibodies, Bacterial | 1 | 2016 | 1479 | 0.090 |
Why?
|
Middle Aged | 13 | 2021 | 223492 | 0.080 |
Why?
|
Cost of Illness | 1 | 2019 | 1951 | 0.080 |
Why?
|
Behavioral Risk Factor Surveillance System | 2 | 2020 | 211 | 0.080 |
Why?
|
Adolescent | 7 | 2021 | 89169 | 0.070 |
Why?
|
Host-Pathogen Interactions | 1 | 2016 | 1469 | 0.070 |
Why?
|
Health Care Costs | 1 | 2019 | 3239 | 0.060 |
Why?
|
Reproducibility of Results | 2 | 2020 | 20227 | 0.060 |
Why?
|
Mycobacterium tuberculosis | 1 | 2016 | 1930 | 0.060 |
Why?
|
Curriculum | 1 | 2019 | 3782 | 0.060 |
Why?
|
Artificial Intelligence | 1 | 2020 | 2665 | 0.060 |
Why?
|
Treatment Outcome | 3 | 2020 | 65371 | 0.060 |
Why?
|
Physicians | 1 | 2022 | 4598 | 0.060 |
Why?
|
Child | 4 | 2020 | 80917 | 0.060 |
Why?
|
Mass Screening | 1 | 2020 | 5458 | 0.060 |
Why?
|
Clinical Competence | 1 | 2019 | 4858 | 0.050 |
Why?
|
Melanoma | 1 | 2020 | 5706 | 0.050 |
Why?
|
Aged | 8 | 2021 | 171504 | 0.050 |
Why?
|
Diabetes Mellitus | 1 | 2019 | 5889 | 0.040 |
Why?
|
Prognosis | 1 | 2020 | 30010 | 0.040 |
Why?
|
Child, Preschool | 2 | 2020 | 42669 | 0.040 |
Why?
|
Keratoderma, Palmoplantar | 1 | 2019 | 17 | 0.040 |
Why?
|
Stereotyping | 1 | 2021 | 241 | 0.040 |
Why?
|
Diagnostic Techniques and Procedures | 1 | 2021 | 219 | 0.040 |
Why?
|
Follow-Up Studies | 1 | 2020 | 39348 | 0.040 |
Why?
|
Risk Factors | 3 | 2020 | 74944 | 0.040 |
Why?
|
Prospective Studies | 2 | 2019 | 54926 | 0.040 |
Why?
|
Review Literature as Topic | 1 | 2019 | 297 | 0.040 |
Why?
|
Pregnancy | 1 | 2020 | 30256 | 0.040 |
Why?
|
Self-Help Groups | 1 | 2019 | 194 | 0.040 |
Why?
|
Scalp | 1 | 2020 | 391 | 0.040 |
Why?
|
Platelet Count | 1 | 2020 | 787 | 0.040 |
Why?
|
Private Sector | 1 | 2020 | 396 | 0.040 |
Why?
|
Physical Examination | 1 | 2022 | 1263 | 0.030 |
Why?
|
Obesity | 1 | 2019 | 13090 | 0.030 |
Why?
|
Mutation | 1 | 2021 | 30238 | 0.030 |
Why?
|
Leukocyte Count | 1 | 2020 | 1609 | 0.030 |
Why?
|
Skin | 2 | 2020 | 4503 | 0.030 |
Why?
|
Hydroxychloroquine | 1 | 2020 | 426 | 0.030 |
Why?
|
Thyroid Diseases | 1 | 2019 | 385 | 0.030 |
Why?
|
Hypothermia, Induced | 1 | 2020 | 754 | 0.030 |
Why?
|
Protein Array Analysis | 1 | 2016 | 399 | 0.030 |
Why?
|
Arthralgia | 1 | 2019 | 459 | 0.030 |
Why?
|
Ultraviolet Rays | 1 | 2020 | 1103 | 0.030 |
Why?
|
Immunoglobulin Fc Fragments | 1 | 2016 | 287 | 0.030 |
Why?
|
Sex Distribution | 1 | 2019 | 2278 | 0.030 |
Why?
|
Video Recording | 1 | 2019 | 976 | 0.030 |
Why?
|
Light | 1 | 2019 | 1355 | 0.030 |
Why?
|
Macrophage Activation | 1 | 2016 | 557 | 0.030 |
Why?
|
Glycosylation | 1 | 2016 | 1100 | 0.030 |
Why?
|
Methotrexate | 1 | 2020 | 1721 | 0.030 |
Why?
|
Statistics, Nonparametric | 1 | 2019 | 2862 | 0.030 |
Why?
|
Receptors, IgG | 1 | 2016 | 564 | 0.030 |
Why?
|
Age Distribution | 1 | 2019 | 2873 | 0.030 |
Why?
|
Interviews as Topic | 1 | 2020 | 2741 | 0.030 |
Why?
|
Triglycerides | 1 | 2020 | 2464 | 0.020 |
Why?
|
Dyslipidemias | 1 | 2019 | 873 | 0.020 |
Why?
|
Adrenal Cortex Hormones | 1 | 2020 | 1886 | 0.020 |
Why?
|
Cholesterol | 1 | 2020 | 2914 | 0.020 |
Why?
|
Aged, 80 and over | 3 | 2020 | 59629 | 0.020 |
Why?
|
Academic Medical Centers | 1 | 2020 | 2784 | 0.020 |
Why?
|
Polysaccharides | 1 | 2016 | 1024 | 0.020 |
Why?
|
Qualitative Research | 1 | 2020 | 3140 | 0.020 |
Why?
|
Self Report | 1 | 2020 | 3773 | 0.020 |
Why?
|
Biopsy | 1 | 2020 | 6793 | 0.020 |
Why?
|
Evidence-Based Medicine | 1 | 2019 | 3706 | 0.020 |
Why?
|
Animals | 1 | 2019 | 169246 | 0.020 |
Why?
|
Physician-Patient Relations | 1 | 2020 | 3269 | 0.020 |
Why?
|
Education, Medical, Graduate | 1 | 2019 | 2420 | 0.020 |
Why?
|
Pilot Projects | 1 | 2019 | 8741 | 0.020 |
Why?
|
Patient Acceptance of Health Care | 1 | 2020 | 3231 | 0.020 |
Why?
|
Sex Factors | 1 | 2020 | 10632 | 0.020 |
Why?
|
Socioeconomic Factors | 1 | 2019 | 7852 | 0.020 |
Why?
|
Early Detection of Cancer | 1 | 2020 | 3239 | 0.020 |
Why?
|
Comorbidity | 1 | 2019 | 10590 | 0.010 |
Why?
|
Age Factors | 1 | 2020 | 18412 | 0.010 |
Why?
|
Health Services Accessibility | 1 | 2020 | 5520 | 0.010 |
Why?
|
Medicare | 1 | 2020 | 6809 | 0.010 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 1 | 2020 | 11878 | 0.010 |
Why?
|
Hypertension | 1 | 2019 | 8616 | 0.010 |
Why?
|
Time Factors | 1 | 2020 | 40218 | 0.010 |
Why?
|
Antineoplastic Agents | 1 | 2020 | 13676 | 0.010 |
Why?
|
Cohort Studies | 1 | 2020 | 41754 | 0.010 |
Why?
|
Breast Neoplasms | 1 | 2020 | 21206 | 0.010 |
Why?
|